On behalf of the editorial board, I am delighted to present to you the first issue of the journal "Advances in Modern Oncology Research (AMOR)".
AMOR is a multidisciplinary, open-access, peerreviewed journal that aims to present to you the latest developments in cancer research and to provide an information exchange platform for a broad audience of medical researchers with interest in cancer research as well as professionals working in the field.
If you are an oncologist, pathologist, radiologist, surgeon, internist, basic science researcher, pharmacist or any other scholar with interest in cancerrelated research, you are more than welcome to contribute your work to AMOR.
Our journal accepts original research articles, review articles, case reports, perspectives and opinion papers whether it is in a clinical or preclinical cancer-related discipline.
Our journal website, www.advmodoncolres.com serves as a platform for all aspects in Advances in Modern Oncology Research (AMOR). From author guidelines, you can learn about our open access policies, it contains all the information the authors will need when deciding whether to submit to the journal. The website is linked to Open Journal Systems (OJS), which is a journal management and publishing system which will facilitate the peerreview process.
We have a database with a great number of peer reviewers, in which the number is still increasing continuously. Our Editorial Board consists of 276 members from 51 countries. The Editorial Board members have diverse expertise in different oncology subspecialties including breast cancer, lung cancer, gynecological malignancies, gastro-intestinal cancers, head and neck cancers, colorectal cancer, genito-urinary cancers, brain tumors, lymphoma, etc. Strict peer review process can ensure high quality paper to be published in this journal.
We promise you a neutral, rigorous, professional and fast editorial and peer review process that will ensure the rapid publication of your high quality article.
We are waiting for your contribution! Omar Abdel-Rahman, PhD Clinical Oncology Department Faculty of Medicine Ain Shams University
